Private investors: FCPI

Investing in innovative SMEs, supporting growth and employment

Channel individual savings into innovative start-ups

  • FCPI (funds dedicated to innovative companies) are funds approved by the AMF that allow individual investors to invest in up-and-coming and innovative unlisted companies.
  • This asset class presents liquidity and loss of capital risks

Invest in technology and life sciences

  • Omnes Capital Venture Capital team manages €700 million in assets under management. For over 20 years, it has successfully supported dynamic and innovative companies in the digital and health sectors.

Benefit from tax incentives

  • Reduces your income tax by an amount equivalent to 18% of your investment (excl. entry charges) up to €2,160 for a single individual (for a maximum investment excl. entry charges of €12,000) or up to €4,320 for a married couple (for an investment of €24,000 excl. entry charges).
    For an investment of €10,000, the incentive works out at 10,000 x 18%, i.e. €1,800
  • In return for blocking assets over a period of 8 years, extendable by 1 year by decision of the management company
FCPI managed by Omnes Capital

Net asset values of Omnes Capital FCPI
> Download the document (French only)

 

The performance of a private equity fund is appreciated over a long investment period. The Net Asset Value may not reflect the potential of the portfolio assets over the life of the Fund and may not reflect the potential evolution of their fair value.

Key figures
20
years’
experience
€700
million
in assets under management
21
FCPI under management
24,000
clients
NewsRoom
Press release
25 June 2007
LCL Régions Développement, a fund managed by Crédit Agricole Private Equity, invests in Ocean
LCL Régions Développement, a fund managed by Crédit Agricole Private Equity, invests in Ocean
Press release
21 June 2007
Crédit Agricole Private Equity announces successful IPO for Amsterdam Molecular Therapeutics B.V. (AMT)
Crédit Agricole Private Equity announces successful IPO for Amsterdam Molecular Therapeutics B.V. (AMT)
Press release
11 June 2007
Crédit Agricole Private Equity finalises sale of independent shoe retailer Béryl to Vivarte
Crédit Agricole Private Equity finalises sale of Béryl to Vivarte
Press release
23 April 2007
CircuLite™ Closes an Additional $5M in Series B Private Placement Funding
CircuLite™ Closes an Additional $5M in Series B Private Placement Funding
Press release
17 April 2007
Successful IPO for METabolic EXplorer Fruitful Partnership between Venture Capital and a Talented Start-up
Successful IPO for METabolic EXplorer Fruitful Partnership between Venture Capital and a Talented Start-up
Press release
16 April 2007
Sparus Software raises €4 million to become Europe's leading vendor of mobile device management software
Sparus Software raises €4 million to become Europe's leading vendor of mobile device management software

Pages